Atlas Trials

Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT00278187 · UNKNOWN

Trial details

NCT number
NCT00278187
Sponsor
Jonsson Comprehensive Cancer Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2005-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.